Administration of tibolone decreases 24 h heart rate but not blood pressure of post-menopausal women

Maturitas

Volumn 48, Issue 2, 2004, Pages 155-160

  Cagnacci, Angelo ^a   Baldassari, Francesco ^a   Arangino, Serenella ^a   Alessandrini, Chiara ^a   Volpe, Annibale ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Blood pressure; Cardiovascular disease; Heart frequency; Menopause; Tibolone

Indexed keywords

PLACEBO; TIBOLONE;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CALCULATION; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEART RATE; HEMODYNAMIC MONITORING; HUMAN; NIGHT; NORMAL HUMAN; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE;

BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; DRUG ADMINISTRATION SCHEDULE; ESTROGEN RECEPTOR MODULATORS; FEMALE; HEART RATE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; NORPREGNENES; POSTMENOPAUSE; TREATMENT OUTCOME;

EID: 2542505406     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2003.08.011     Document Type: Article

References (31)

1. van der Vies J. Pharmacological studies with ((7α, 17α)-17hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-one) (Org OD14). Maturitas 1987;Suppl 1:15-24.
2. Moore R.A. Livial: a review of clinical studies. Br. J. Obstet. Gynaecol. 106(Suppl 19):1999;1-21
3. Hanggi W., Lippuner K., Riesen W., Jaeger P., Birkhauser M. Long term influence of different post-menopausal hormone replacement regimens on serum lipids and lipoprotein(a): a randomised study. Br. J. Obstet. Gynaecol. 104:1997;708-717
4. Castelo-Branco C., Casalas E., Figueras F., et al. Two-year prospective and comparative study on the effects of tibolone on lipid pattern. Menopause. 6:1999;92-97
5. Farish E., Narnes J.F., Fletcher C.D., Ekevall K., Calder A., Hart D.M. Effects of tibolone on serum lipoprotein and apolipoprotein levels compared with a cyclical estrogen/progestogen regimen. Menopause. 6:1999;98-104
6. Cagnacci A., Mallus E., Tuveri F., Cirillo R., Setteneri A.M., Melis G.B. Effect of tibolone on glucose and lipid metabolism in post-menopausal women. J. Clin. Endocrinol. Metab. 82:1997;251-253
7. Wiegratz I., Starflinger F., Tezloff W., et al. Effect of tibolone compared with sequential hormone replacement therapy on carbohydrate metabolism in post-menopausal women. Maturitas. 41:2002;133-141
8. Celik H., Ayar A., Tug N., Cikim G., Kilic N., Parmaksiz C. Effect of tibolone on plasma homocysteine levels in post-menopausal women. Fertil. Steril. 78:2002;347-350
9. Garnero P., Jamin C., Benhamou C.-L., Pelissier C., Roux C. Effects of tibolone and combined 17β-estradiol and norethisterone acetate on serum C-reactive protein in healthy post-menopausal women: a randomized trial. Hum. Reprod. 17:2002;2748-2753
10. Hardiman P., Nihoyannopoulos P., Kicovic P., Ginsburg J. Cardiovascular effects of Org OD14 - a new steroidal therapy for climacteric symptoms. Maturitas. 13:1991;235-242
11. August P., Oparil S. Hypertension in women. J. Clin. Endocrinol. Metab. 84:1999;1862-1866
12. Prelevic G.M., Beljic T., Ginsburg J. The effect of tibolone on cardiac flow in post-menopausal women with non-insulin dependent diabetes mellitus. Maturitas. 27:1997;85-90
13. Lloyd G.W., Patel N.R., McGing E.A., Cooper A.E., Kamalvand K., Jackson G. Acute effects of hormone replacement with tibolone on myocardial ischemia in women with angina. Int. J. Clin. Pract. 52:1998;155-157
14. Prelevic G.M., Kwong P., Byrne D.J., et al. A cross-sectional study on the effects of hormone replacement therapy on the cardiovascular disease risk profile in healthy post-menopausal women. Fertil. Steril. 77:2002;945-951
15. Lloyd G., McGing E., Cooper A., et al. A randomized placebo controlled trial of the effects of tibolone on blood pressure and lipids in hypertensive women. J. Hum. Hypertens. 14:2000;99-104
16. Feher M.D., Cox A., Levy A., Mayne P., Lant A.F. Short term blood pressure and metabolic effects of tibolone in post-menopausal women with non-insulin dependent diabetes. Br. J. Obstet. Gynaecol. 103:1996;281-283
17. Verdecchia P. Prognostic value of ambulatory blood pressure. Current evidence and clinical implications. Hypertension. 35:2000;844-851
18. Okhubo T., Imai Y., Tsuji I., et al. Relation between nocturnal decline in blood pressure and mortality: the Ohasama study. Am. J. Hypertens. 10:1997;1201-1207
19. Staessen J.A., Thijs L., Fagard R., et al. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators Predicting cardiovascular risk using conventional vs. ambulatory blood pressure in older patients with systolic hypertension. JAMA. 282:1999;539-546
20. Akkad A.A., Halligan A.W.F., Abrams K., Al-Azzawi F. Differing responses in blood pressure over 24 hours in normotensive women receiving oral or transdermal estrogen replacement therapy. Obstet. Gynecol. 89:1997;97-103
21. Cagnacci A., Rovati L., Zanni A.L., Malmusi S., Facchinetti F., Volpe A. Physiological doses of estradiol decrease nocturnal blood pressure in normotensive post-menopausal women. Am. J. Physiol. 276:1999;H1355-H1360
22. Seely E.W., Walsh B.W., Gerhard M.A., Williams C.H. Estradiol with or without progesterone and ambulatory blood pressure in post-menopausal women. Hypertension. 33:1999;1190-1194
23. Vongpatanasin W., Tuncel M., Mansour Y., Arbique D., Victor R.G. Transdermal estrogen replacement therapy decreases sympathetic activity in post-menopausal women. Circulation. 103:2001;2903-2908
24. Manwaring P., Morfis L., Diamond T., Howes L.G. Effects of hormone replacement therapy on ambulatory blood pressure and vascular responses in normotensive women. Blood Press. 9:2000;22-27
25. Mercuro G., Zoncu S., Piano D., et al. Estradiol-17β reduces blood pressure and restores the normal amplitude of the circadian blood pressure rhythm in post-menopausal women. Am. J. Hypertens. 11:1998;909-913
26. Hayward C.S., Samaras K., Campbell L., Kelly R.P. Effect of combination hormone replacement therapy on ambulatory blood pressure and arterial stiffness in diabetic post-menopausal women. Am. J. Hypertens. 14:2001;699-703
27. Beere P.A., Glagov S., Zarins C.K. Retarding effect of lowered heart rate on coronary atherosclerosis. Science. 226:1984;180-182
28. Kaplan J.R., Manuck S.B., Adams M.R., Weingand K.W., Clarkson T.B. Inhibition of coronary atherosclerosis by propanolol in behaviorally predisposed monkeys fed an atherogenic diet. Circulation. 76:1987;1364-1372
29. Palatini P., Casiglia E., Pauletto P., Staessen J., Kaciroti N., Julius S. Relationship of tachycardia with high blood pressure and metabolic abnormalities. A study with mixture analysis in three populations. Hypertension. 30:1997;1267-1273
30. Deibert D.C., DeFronzo R.A. Epinephrine-induced insulin resistance in man. J. Clin. Invest. 65:1979;717-721
31. Polare T., Lithell H., Selinus I., Berne C. Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension. Diabetologia. 31:1988;415-420